Big Gain For Celldex Therapeutics, Inc.
Mon 15 Jun 20 at 05:30 PM
Celldex Therapeutics, Inc. (CLDX:NASDAQ) rocketted at $10.71, a gain of 37.3%. On Fri 12 Jun 20, CLDX:NASDAQ touched a New 2-Week Intraday High of $9.88. The stock got featured on our News Catalysts scanner on Mon 15 Jun 20 at 05:24 PM in the 'PUBLIC OFFERING' category. From Fri 29 May 20, the stock recorded 50.00% Up Days and 72.73% Green Days
The stock spiked on Thu 11 Jun 20 at $10.16 with a volume of 59M+.
About Celldex Therapeutics, Inc. (CLDX:NASDAQ)
Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
Top 10 Gainers:
- Urban One, Inc. (UONE:NASDAQ), 255.43%
- Edesa Biotech, Inc. (EDSA:NASDAQ), 101.39%
- China HGS Real Estate Inc. (HGSH:NASDAQ), 72%
- Urban Tea, Inc. (MYT:NASDAQ), 66.41%
- The9 Limited (NCTY:NASDAQ), 61.97%
- Novan, Inc. (NOVN:NASDAQ), 61.84%
- Birks Group Inc. (BGI:NYSEMKT), 54.6%
- Net Element, Inc. (NETE:NASDAQ), 50%
- Brickell Biotech, Inc. (BBI:NASDAQ), 50%
- Celldex Therapeutics, Inc. (CLDX:NASDAQ), 37.31%